Pramlintide dose guide

A peptide dosage chart, one peptide at a time: its dose range, how often it’s taken, a typical run and the units on your syringe. 84 peptides from the PepVault library.

A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.

Pramlintide dosage

The first amylin drug (Symlin), approved in 2005 for people with diabetes who use mealtime insulin: a shot before each main meal that slows digestion and makes people feel full sooner. In its diabetes trials weight fell about 1 to 2 kg, and in obesity trials without insulin, weight loss of about 6 to 7 kg beyond placebo was seen at a year. Commonly reported: early fullness and nausea in the first weeks. It is the short-acting ancestor of weekly cagrilintide, and its US pens are being discontinued.

Dose range
15–120 mcg (fda label).
How often
2–3× daily: 2–3x daily SubQ, right before major meals
A typical run
Ongoing. FDA-approved for ongoing use with mealtime insulin; its placebo-controlled trials ran 26 to 52 weeks. If it is stopped (surgery, illness), the label restarts it with the same start-up steps.
How it’s taken
Vial: SubQ injection
Evidence
Established: Clinical trials or FDA-approved use exists
Half-life
~0.8 hours (48 minutes, FDA label)

Pramlintide on your syringe

Sold ready to use, never as a powder you mix, so there’s no mix to work out.

Newsletter · Weekly

The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

We’ll email you a link to confirm. Your address is used for the briefing only. Privacy

Track the doses you run

PepVault logs every dose, keeps count of the doses left in your vials, and reminds you on your schedule.

Get PepVault on the App Store7 days free on the yearly plan for new subscribers.

More glp-1 & metabolic peptides

A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.